Skip to main content

Advertisement

Log in

Calprotectin, RAGE and TNF-α in hypertensive disorders in pregnancy: expression and significance

Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

To investigate the expression of calprotectin, the receptor of advanced glycation end products (RAGE) and tumor necrosis factor-α (TNF-α) in hypertensive disorders in pregnancy as well as the significance of their expression.

Methods

The research assessed levels of plasma calprotectin and TNF-α using the enzyme-linked immunosorbent assay, and expression of calprotectin, RAGE and TNF-α in placenta tissues using the immunohistochemistry streptavidin–peroxidase (S–P) method in 60 women with hypertensive disorders in pregnancy and 32 women with normal pregnancy (as the controls).

Results

Compared with the control group, the levels of calprotectin, RAGE and TNF-α were elevated in plasma or placenta tissues in the group with hypertensive disorders in pregnancy, and were positively correlated with severity of hypertensive disorders in pregnancy. The levels of calprotectin were consistent with TNF-α in plasma and placenta tissues in the group with hypertensive disorders in pregnancy.

Conclusion

Changes in calprotectin, RAGE and TNF-α levels in maternal serum and placental tissue correlate to the pathogenesis and disease progression of hypertensive disorders in pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Corrêa RR, Gilio DB, Cavellani CL et al (2008) Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy. Arch Gynecol Obstet 277(3):201–206

    Article  PubMed  Google Scholar 

  2. Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, Dale I (1997) Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 50(3):113–123

    Article  CAS  PubMed  Google Scholar 

  3. Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A, Varki N, Kronenberg M, Freeze HH, Srikrishna G (2008) RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29(10):2035–2043

    Article  CAS  PubMed  Google Scholar 

  4. Apel-Sarid L, Levy A, Holcberg G, Sheiner E (2009) Placental pathologies associated with intra-uterine fetal growth restriction complicated with and without oligohydramnios. Arch Gynecol Obstet 280(4):549–552

    Article  PubMed  Google Scholar 

  5. Feinshtein V, Ben-Zvi Z, Sheiner E, Amash A, Sheizaf B, Holcberg G (2009) Progesterone levels in cesarean and normal delivered term placentas. Arch Gynecol Obstet

  6. Polachek H, Holcberg G, Polachek J, Rubin M, Feinshtein V, Sheiner E, Ben-Zvi Z (2009) Carrier-mediated uptake of levofloxacin by BeWo cells, a human trophoblast cell line. Arch Gynecol Obstet

  7. Roberts JM, Lain KY (2002) Recent insights into the pathogenesis of pre-eclampsia. Placenta 23(5):359–372

    Article  CAS  PubMed  Google Scholar 

  8. Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW (1994) A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 171(1):158–164

    CAS  PubMed  Google Scholar 

  9. Sharma A, Satyam A, Sharma JB (2007) Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 58(1):21–30

    Article  CAS  PubMed  Google Scholar 

  10. Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S (2007) The role of inflammation and infection in preterm birth. Semin Reprod Med 25(1):21–39

    Article  CAS  PubMed  Google Scholar 

  11. Romero R, Espinoza J, Mazor M (2004) Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril 82(4):799–804

    Article  PubMed  Google Scholar 

  12. Hsu CD, Witter FR (1995) Urogenital infection in preeclampsia. Int J Gynaecol Obstet 49(3):271–275

    Article  CAS  PubMed  Google Scholar 

  13. Canakci V, Canakci CF, Canakci H, Canakci E, Cicek Y, Ingec M, Ozgoz M, Demir T, Dilsiz A, Yagiz H (2004) Periodontal disease as a risk factor for pre-eclampsia: a case control study. Aust NZ J Obstet Gynaecol 44(6):568–573

    Article  Google Scholar 

  14. Herrera JA, Chaudhuri G, López-Jaramillo P (2001) Is infection a major risk factor for preeclampsia? Med Hypotheses 57(3):393–397

    Article  CAS  PubMed  Google Scholar 

  15. Redman CW, Sacks GP, Sargent IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180(2):499–506

    Article  CAS  PubMed  Google Scholar 

  16. Passey RJ, Xu K, Hume DA, Geczy CL (1999) S100A8: emerging functions and regulation. J Leukoc Biol 66(4):549–556

    CAS  PubMed  Google Scholar 

  17. Kerkhoff C, Klempt M, Sorg C (1998) Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1448(2):200–211

    Article  CAS  PubMed  Google Scholar 

  18. Yui S, Nakatani Y, Mikami M (2003) Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 26(6):753–760

    Article  CAS  PubMed  Google Scholar 

  19. Stríz I, Trebichavský I (2004) Calprotectin—a pleiotropic molecule in acute and chronic inflammation. Physiol Res 53(3):245–253

    PubMed  Google Scholar 

  20. Hung TH, Charnock-Jones DS, Skepper JN et al (2004) Secretion Of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 164(3):1049–1061

    CAS  PubMed  Google Scholar 

  21. Nakagami H, Cui TX, Iwai M, Shiuchi T, Takeda-Matsubara Y, Wu L, Horiuchi M (2002) Tumor necrosis factor-alpha inhibits growth factor-mediated cell proliferation through SHP-1 activation in endothelial cells. Arterioscler Thromb Vasc Biol 22(2):238–242

    Article  CAS  PubMed  Google Scholar 

  22. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW (1995) Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 102(1):20–25

    Article  CAS  PubMed  Google Scholar 

  23. Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B (2001) Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81(8):1143–1152

    CAS  PubMed  Google Scholar 

  24. Laivuori H, Kaaja R, Koistinen H et al (2000) Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metabolism 49(2):259–263

    Article  CAS  PubMed  Google Scholar 

  25. Knackstedt M, Ding JW, Arck PC et al (2001) Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. Am J Reprod Immunol 46(3):196–210

    Article  CAS  PubMed  Google Scholar 

  26. Larsson PT, Hallerstam S, Rosfors S et al (2005) Circulating markers of inflammation are related to carotid artery atherosclerosis. Int Angiol 24(1):43–51

    CAS  PubMed  Google Scholar 

  27. Newton RA, Hogg N (1998) The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160(3):1427–1435

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tao Shang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feng, C., Tao, Y., Shang, T. et al. Calprotectin, RAGE and TNF-α in hypertensive disorders in pregnancy: expression and significance. Arch Gynecol Obstet 283, 161–166 (2011). https://doi.org/10.1007/s00404-009-1303-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-009-1303-x

Keywords

Navigation